Lash & Goldberg LLP served as co-counsel for its named plaintiff client in this federal antitrust class action against Bristol-Myers alleging the unlawful monopolization of the national market for paclitaxel, a cancer drug sold under the brand name Taxol.
Lash & Goldberg LLP represented several South Florida hospitals of a national health system against Beech Street, a national brokered preferred provider organization. The hospitals contended that Beech Street improperly allowed fraudulent and unlicensed payers to access the preferred provider network, exposing the hospitals to claims for medical services that could not, and would not, be paid by the fraudulent entities.
After six years of litigation, Lash & Goldberg LLP obtained two partial summary judgments that resulted in the dismissal of the entire case against a Miami-Dade hospital and its national parent. The case, brought by six neonatologists, included claims for breach of contract, tortious interference with advantageous business relationships, violations of the antitrust statutes and injunctive and declaratory relief.
Lash & Goldberg LLP represented a South Florida hospital in a federal lawsuit brought by Aptium Oncology, the manager of the hospital’s outpatient cancer center and an affiliate of AstraZeneca LLC. The manager asserted claims for breach of a management services agreement, tortious interference and unfair and deceptive trade practices, and sought more than $50 million in damages from the hospital.
After more than five years of protracted litigation, Lash & Goldberg LLP favorably resolved a national consumer class action against a national health system and an affiliate in federal court. The complaint asserted that the defendants had engaged in a pattern and practice of unlawfully “balance billing” class member-patients in violation of state and federal consumer protection laws.